TGFB1 and renal fibrosis: ICG-001 inhibited the β-catenin/TCF interaction, reducing MMT in bone marrow-derived macrophages during renal fibrosis and enhancing the anti-inflammatory effect of TGF-β on bone marrow-derived macrophages, leading to reduced renal fibrosis in the UUO model (84) (Figure 2).